![Menassie Taddese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 153 042 $ al 30/06/2026
Mr. Menassie Taddese is an Independent Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Medexus Pharmaceuticals, Inc. Mr. Taddese was previously employed as a President-Emerging Markets by Viatris, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/09/2025 | 42.869 ( 0,14 % ) | 153 042 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Director/Miembro de la Junta | 06/02/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01/12/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Medexus Pharmaceuticals, Inc.
 Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
